Rovelizumab is a humanized моноклональный leukointegrin антитело. Rovelizumab is a моноклональный антитело directed against the CD11/CD18 клетка adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.